Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announces the appointments of David Bryant and
UK bond demand hits lowest level of the year
This year, demand for UK debt dropped to its lowest point following Rachel Reeves’s Budget, which fueled expectations of rising bond yields.